Ruben Valente

Mr. Ruben Valente

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
SCSandra Cordeiro
Sandra Cordeiro
BOBeatriz Oliveira
Beatriz Oliveira
RVRuben Valente
Ruben Valente
DFDaniela Ferreira
Daniela Ferreira
ALAndré Luz
André Luz
Alexandra FernandesAlexandra Fernandes
Alexandra Fernandes
Despite extensive efforts to unravel tumor behavior and develop anticancer therapies, most treatments fail when advanced to clinical trials. The main challenge in cancer research has been the absence of predictive cancer models, accurately mimicking the tumoral processes and response to treatments. The tumor microenvironment (TME) shows several human-specific physical and chemical properties, which cannot be fully recapitulated by the conventional 2D cell cultures or the in vivo animal models. These limitations have driven the development of novel in vitro cancer models, that get one step closer to the typical features of in vivo systems while showing better species relevance. This review introduces the main considerations required for developing and exploiting tumor spheroids and organoids as cancer models. We also detailed their applications in drug screening and personalized medicine. Further, we show the transition of these models into novel microfluidic platforms, for improved control over physiological parameters and high-throughput screening. 3D culture models have provided key insights into tumor biology, more closely resembling the in vivo TME and tumor characteristics, while enabling the development of more reliable and precise anticancer therapies.

13 January 2021 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
DSDiogo Sequeira
Diogo Sequeira
Pedro BaptistaPedro Baptista
Pedro Baptista
RVRuben Valente
Ruben Valente
MPM. Fátima M. Piedade
M. Fátima M. Piedade
MGM. Helena Garcia
M. Helena Garcia
Alexandra FernandesAlexandra Fernandes
Alexandra Fernandes
Cancer is one of the worst health issues worldwide, representing the second leading cause of death. Current chemotherapeutic drugs face some challenges like the acquired resistance of the tumoral cells and low specificity leading to unwanted side effects. There is an urgent need to develop new compounds that may target resistant cells. The synthesis and characterization of two Cu(I) complexes of general formula [Cu(PP)(LL)][BF4], where PP is a phosphane ligand (triphenylphosphine or 1,2-bis(diphenylphosphano) ethane) and LL = is a heteroaromatic bidentate ligand (4,4′-dimethyl-2,2′-bipyridine and 6,3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine). The new compounds were fully characterized by spectroscopic techniques (NMR, FTIR and UV-vis.), elemental analysis (C, H, N and S) and two structures were determined by single X-ray diffraction studies. The antiproliferative potential of the new Cu(I) complexes were studied in tumor (breast adenocarcinoma, ovarian carcinoma and in colorectal carcinoma sensitive and resistant to doxorubicin) and normal (fibroblasts) cell lines. Complexes 1–4 did not show any antiproliferative potential. Amongst the complexes 5–8, complex 8 shows high cytotoxic potential against colorectal cancer sensitive and resistant to doxorubicin and low cytotoxicity towards healthy cells. We show that complexes 5–8 can cleave pDNA and, in particular, the in vitro pDNA cleavage is due to an oxidative mechanism. This oxidative mechanism corroborates the induction of reactive oxygen species (ROS), that triggers HCT116 cell death via apoptosis, as proved by the increased expression of BAX protein relative to BCL-2 protein and the depolarization of mitochondrial membrane potential, and via autophagy. Additionally, complex 8 can block the cell cycle in the G1 phase, also exhibiting a cytostatic potential. Proteomic analysis confirmed the apoptotic, autophagic and cytostatic potential of complex 8, as well as its ability to produce ROS and cause DNA damage. The interference of the complex in folding and protein synthesis and its ability to cause post-translational modifications was also verified. Finally, it was observed that the complex causes a reduction in cellular metabolism. The results herein demonstrated the potential of Cu(I) complexes in targeting doxorubicin sensitive and resistant cells which is positive and must be further explored using in vivo animal models.

Verified
Journal Article
Open access
PDF file
AAAna F. Amendoeira
Ana F. Amendoeira
ALAndré Luz
André Luz
RVRuben Valente
Ruben Valente
Catarina Roma-RodriguesCatarina Roma-Rodrigues
Catarina Roma-Rodrigues
HAHasrat Ali
Hasrat Ali
Alexandra FernandesAlexandra Fernandes
Alexandra Fernandes
Estradiol-BODIPY linked via an 8-carbon spacer chain and 19-nortestosterone- and testosterone-BODIPY linked via an ethynyl spacer group were evaluated for cell uptake in the breast cancer cell lines MCF-7 and MDA-MB-231 and prostate cancer cell lines PC-3 and LNCaP, as well as in normal dermal fibroblasts, using fluorescence microscopy. The highest level of internalization was observed with 11β-OMe-estradiol-BODIPY 2 and 7α-Me-19-nortestosterone-BODIPY 4 towards cells expressing their specific receptors. Blocking experiments showed changes in non-specific cell uptake in the cancer and normal cells, which likely reflect differences in the lipophilicity of the conjugates. The internalization of the conjugates was shown to be an energy-dependent process that is likely mediated by clathrin- and caveolae-endocytosis. Studies using 2D co-cultures of cancer cells and normal fibroblasts showed that the conjugates are more selective towards cancer cells. Cell viability assays showed that the conjugates are non-toxic for cancer and/or normal cells. Visible light irradiation of cells incubated with estradiol-BODIPYs 1 and 2 and 7α-Me-19-nortestosterone-BODIPY 4 induced cell death, suggesting their potential for use as PDT agents.

26 July 2026 in ChemMedChem
Verified
Journal Article
Open access
PDF file
MMM. Margarida Martins
M. Margarida Martins
RVRuben Valente
Ruben Valente
RARuben Amaro
Ruben Amaro
MVMaria S. Viana
Maria S. Viana
RJRita de Jesus
Rita de Jesus
Luisa FerreiraLuisa Ferreira
Luisa Ferreira
The development of new therapeutic agents for glioblastoma and hepatocellular carcinoma (HCC) remains a priority due to poor prognosis, limited treatment options, and high recurrence rates. Herein, we report a one‐pot synthesis of aromatic aminopropyl lactams (ArAPLs) via hydrolysis of bicyclic amidines (DBN, DBU), followed by reductive amination with aromatic aldehydes. These compounds were designed to target histamine H 3 receptors (H 3 R), which are often overexpressed in these malignancies. Docking studies suggested that compounds 3a and 4a may act as H 3 R antagonists, showing favorable binding through hydrophobic and hydrogen‐bonding interactions. Biological evaluation identified 3a and 4a as the most promising compounds, exhibiting micromolar antiproliferative activity in glioblastoma and HCC cell models. Compound 3a showed the best balance between potency and selectivity, including activity in 3D spheroid models and modulation of cell cycle‐related markers. In coculture systems, spheroids displayed reduced size and density, although a slight increase in viability was observed, particularly with 4a . Variations in peripheral cell layers suggest a role for macrophage behavior. Overall, these findings support the cytotoxic potential of ArAPLs, although further studies are required to confirm their role as H 3 R antagonists.

25 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FMFilipe Magalhães
Filipe Magalhães
CAClaúdia Andrade
Claúdia Andrade
BSBeatriz Simões
Beatriz Simões
FBFredi Brigham
Fredi Brigham
RVRuben Valente
Ruben Valente
Ana Varela CoelhoAna Varela Coelho
Ana Varela Coelho
The potential to regenerate a damaged body part is expressed to a different extent in animals. Echinoderms, in particular starfish, are known for their outstanding potential to regenerate cell, tissue, organ, and body parts. For instance, humans have restricted abilities to restore organ systems being dependent on limited sources of stem cells. In particular, the potential to regenerate the central nervous system is extremely limited, explaining the lack of natural mechanisms that could overcome the development of neurodegenerative diseases and the presence of traumatisms. Therefore, understanding the molecular and cellular mechanisms of regeneration in starfish could lead to the development of new therapeutic approaches in humans. In this study, we tackle the problem of starfish central nervous system regeneration by examining anatomical and behavioral traits, including external anatomic anomalies, the dynamics of coelomocytes populations and neuronal tissue architecture. We noticed that several anatomic anomalies were evident and detected that the injured arm could not be used anymore to lead the starfish movement. Those seem to be related to defense mechanisms and protection of the wound. In particular, histology showed that tissue patterns during regeneration resemble those described in holothurians and in starfish arm tip regeneration. Flow cytometry coupled with imaging flow cytometry unveiled a new coelomocyte population during the late phase of the regeneration process. Morphotypes of previously characterized coelomocytes populations were described based on IFC data. Further studies of this new coelomocyte population might provide insights on their involvement in radial nerve cord regeneration.

1 January 2026 in Dalton Transactions
Verified
Journal Article
Closed access
HRHadi Amiri Rudbari
Hadi Amiri Rudbari
KFKimia Forooghi
Kimia Forooghi
ZKZahra Kazemi
Zahra Kazemi
BSBeatriz Salas
Beatriz Salas
MSMehdi Sahihi
Mehdi Sahihi
Alexandra FernandesAlexandra Fernandes
Alexandra Fernandes
Three halogenated Pd( ii ) complexes were synthesized and characterized spectroscopically, crystallographically, and computationally, then evaluated for DNA binding and anticancer activity in 2D/3D models of doxorubicin-resistant colorectal cancer.